Exposure to hydrogen peroxide induces cell death via apoptosis in primary cultured mouse hepatocytes

Biological and Pharmaceutical Bulletin

Volumn 22, Issue 12, 1999, Pages 1296-1300

  Kanno, Shuuichi ^a   Ishikawa, Masaaki ^a   Takayanagi, Motoaki ^a   Takayanagi, Yoshio ^a   Sasaki, Ken Ichi ^a  

^a TOHOKU PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Apoptosis; Oxidative damage; Oxidative stress; Reactive oxygen species

Indexed keywords

ACETYLCYSTEINE; DNA FRAGMENT; HYDROGEN PEROXIDE; OXIDIZING AGENT; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CULTURE; CONTROLLED STUDY; CYTOTOXICITY; EXPOSURE; LIVER CELL; LIVER TOXICITY; MOUSE; NONHUMAN; OXIDATION; OXIDATIVE STRESS;

EID: 0033372991     PISSN: 09186158     EISSN: None     Source Type: Journal    
DOI: 10.1248/bpb.22.1296     Document Type: Article

References (23)

1. Que F., Gores G. J., "Apoptosis: Pharmacological Implications and Therapeutic Opportunities," ed. by Kaufmann S. H., Advances in Pharmacology, Vol. 41, Academic Press, San Diego, London, Boston, New York, Tokyo, Toronto, 1997, pp. 409-428.
2. Wolfe J. T., Ross D., Cohen G. M., FEBS Lett., 352, 58-62 (1994).
3. Buttke T. M., Sandstrom P. A., Immunol. Today, 15, 7-12 (1994).
4. Tanaka K., Sato M., Tomita Y., Ichihara A., J. Biochem. (Tokyo), 84, 937-946 (1978).
5. Bruno M. K., Cohen S. D., Khairallah E. A., Biochem. Pharmacol., 37, 4319-4325 (1988).
6. Gavrieli Y., Scherman Y., Ben-Sasson S. A., J. Cell Biology, 119, 493-501 (1992).
7. Hermann H., Nucleic Acids Res., 24, 5506-5511 (1984).
8. Kanno S., Ishikawa M., Nemoto S., Takayanagi Y., Sasaki K., Abstract of Papers. 37th Tohoku Regional Meeting of the Pharmaceutical Society of Japan, Morioka, October, 1998, p. 67 (in Japanese).
9. Hockenberry D. M., Olitvai Z. N., Yin X.-M., Milliman C. L., Korsmeyer S. J., Cell. 75, 241-250 (1993).
10. Schulze-Osthoff K., Bakker A. C., Vanhesebroeck B., Beyaert R., Jacob W. A., Fiers W., J. Biol. Chem., 267, 5317-5323 (1992).
11. Ueda N., Shah S. V., J. Clin. Invest., 90, 2593-2597 (1992).
12. Lennon S. V., Martin S. J., Cotter T. G., Cell Prolif., 24, 203-208 (1991).
13. Albina J. E., Cui S., Mateo R. B., J. Immunol., 150, 5080-5085 (1993).
14. Ratan R. R., Murphy T. H., Baraban J. M., J. Neurochem., 62, 376-379 (1994).
15. a) Shen W., Kamendulis L. M., Ray S. D., Corcoran G. B., Toxicol. Appl. Pharmacol., 112, 32-40 (1992);
16. b) Kanno S., Ishikawa M., Takayanagi M., Takayanagi Y., Sasaki K., Abstract of Papers, 47th Hokubu Meeting of the Japanese Pharmacological Society, 1996, p. 79 (in Japanese).
17. a) Butterworth M., Upshall D. G., Smith L. L., Cohen G. M., Biochem. Pharmacol., 43, 483-489 (1992);
18. b) Roberts J. C., Charyulu R. L., Zera R. T., Nagasawa H. T., Pharmacol. Toxicol., 70, 281-285 (1992),
19. c) Thomas S. H. L., Pharmac. Ther., 60, 91-115 (1993).
20. Black M., Annu. Rev. Med., 35, 577-593 (1984).
21. Kroger H., Dietrich A., Ohde M., Lange R., Ehrlich W., Kurpisz M., Gen. Pharmacol., 28, 257-262 (1997).
22. Michael S. L., Pumfored N. R., Mayeurx P. R., Niesman M. R., Hinson J. A., Hepatology, 30, 186-191 (1999).
23. Van Dyke K., Sacks M., Qazi N., J. Biolumin. Chemilumin, 13, 339-344 (1998).